Quarterly Results

  • Company Name :
Rubicon Research Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 544578
  • NSE Symbol:
  • RUBICON
  • P/E(TTM):
  • 64.49
  • ISIN Demat:
  • INE506V01022
  • Div & Yield%:
  • 0.00
  • EPS(TTM):
  • 10.17
  • Book Value(₹):
  • 71.10
  • Market Cap(₹Cr.):
  • 10,805.97
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)September 2024 ( Cr)
Gross Sales 336.47 278.03 254.90
Excise Duty 0.00 0.00 0.00
Net Sales 336.47 278.03 254.90
Other Operating Income 0.00 0.00 0.00
Other Income 1.51 1.44 2.82
Total Income 337.98 279.46 257.72
Total Expenditure 257.37 214.89 186.49
PBIDT 80.61 64.58 71.23
Interest 9.21 8.85 6.38
PBDT 71.41 55.73 64.85
Depreciation 9.78 8.30 7.32
Tax 19.12 10.05 15.30
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -3.30 2.23 -0.65
Reported Profit After Tax 45.81 35.15 42.89
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 45.81 35.15 42.89
EPS (Unit Curr.) 2.97 2.28 2.82
EPS (Adj) (Unit Curr.) 2.97 2.28 2.82
Calculated EPS (Unit Curr.) 2.97 2.28 2.78
Calculated EPS (Adj) (Unit Curr.) 2.97 2.28 2.78
Calculated EPS (Ann.) (Unit Curr.) 11.87 9.12 11.13
Calculated EPS (Adj) (Ann.) (Unit Curr.) 11.87 9.12 11.13
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 15.44 15.41 15.41
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 23.96 23.23 27.94
PBDTM(%) 21.22 20.04 25.44
PATM(%) 13.61 12.64 16.83